Verona Pharma plc — Director's Dealing 2024

Nov 18, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Verona Pharma plc (VRNA)
CIK: 0001657312
Period of Report: 2024-11-18

Reporting Person: EBSWORTH DAVID R (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-11-18	Ordinary Shares	P	20000	$4.44	Acquired	940003	Direct

Footnotes

F1: Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.

F2: Consists of (i) 940,000 Ordinary Shares represented by 117,500 ADSs and (ii) 3 Ordinary Shares.